Search

The European Medicines Agency (EMA) is exploring an improved approach for biosimilar medicine development and evaluation, while upholding strict European Union (EU) safety standards. The is outlined in a draft reflection paper biosimilar development. Its aim is to reduce the amount of clinical data required for the development and approval of...

The European Medicines Agency (EMA) publishes calls for tender for the supply of goods, services and works. Interested suppliers need to apply to an EMA procurement procedure or respond to a call for expressions of interest to be preselected as a potential candidate for restricted invitations to tender. EMA uses the Funding & Tenders Portal and the...